Changes in oxytocin content in rat brain during morphine withdrawal
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In this study the modification in the oxytocin content in different hypothalamic nuclei during morphine withdrawal was analysed. Male rats were implanted with placebo (naïve) or morphine (tolerant/dependent) pellets for 7 days. On day 7, groups of rats received an acute injection of saline s.c. (control) or naloxone (1 mg/kg s.c.) and were decapitated 30 min later. After administration of naloxone to tolerant rats (withdrawal) an increase in the oxytocin content in the paraventricular nucleus (PVN) and median eminence (ME) was found. No changes were found in the arcuate nucleus (AN) and supraoptic nucleus (SON). Present data demonstrate that administration of naloxone to tolerant rats alters the brain oxytocin system, which suggests that this peptide might contribute to the behavioural, emotional and neuroendocrine response to opioid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Oxytocin unlike vasopressin is a stress hormone in the rat.
Lang, R. E., Heil, J. W. E., Ganten, D., Hermann, K., Unger, T., & Rascher, W. (2008) · Neuroendocrinology · doi:10.1159/000123566 · Cited by 304
Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress
Gibbs, D. M. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90241-8 · Cited by 233
Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones
Clarke, G., Wood, P., Merrick, L., & Lincoln, D. W. (1979) · Nature · doi:10.1038/282746a0 · Cited by 219
LIGHTMAN, S. L., & YOUNG, W. S. (1989) · Endocrinology · doi:10.1210/endo-124-5-2358 · Cited by 184
Hayward, M. D., Duman, R. S., & Nestler, E. J. (1990) · Brain Research · doi:10.1016/0006-8993(90)90872-9 · Cited by 181
Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal
Lightman, S. L., & Young III, W. S. (1987) · Nature · doi:10.1038/328643a0 · Cited by 161
Da Costa, A. P. C., Guevara‐Guzman, R. G., Ohkura, S., Goode, J. A., & Kendrick, K. M. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.04411.x · Cited by 134
Arnauld, E., Cirino, M., Layton, B. S., & Renaud, L. P. (1983) · Neuroendocrinology · doi:10.1159/000123455 · Cited by 123
A neural circuitry analysis of maternal behavior in the rat
Numan, M. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13261.x · Cited by 118
Research works printed but not linked: 2
- Russel, 1992, Morphine withdrawal excitation induces c-fos gene expression in rat magnocellular oxytocin neurons, Soc Neurosci Abst, 18, 822
- Johnstone, 1993, Excitation by morphine withdrawal induces c-fos expression in magnocellular oxytocin neurons, Br J Pharmacol, 109, 104P
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Increases in oxytocin content in the PVN and median eminence were observed during naloxoneprecipitated morphine withdrawal (Laorden et al., 1998).”
BackgroundThe role of oxytocin in alcohol and drug abuse
King, C. E., Gano, A., & Becker, H. C. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146761 · Cited by 66
Oxytocin and opioid addiction revisited: old drug, new applications
Zanos, P., Georgiou, P., Weber, C., Robinson, F., Kouimtsidis, C., Niforooshan, R., & Bailey, A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13757 · Cited by 55
“, 2000) and OT mRNA levels within the median eminence and PVN (Laorden et al., 1998), which may illustrate an increase in the biosynthesis of OT.”
BackgroundInfluentialGuen, S. L., Gestreau, C., & Besson, J. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1140 · Cited by 36
“The dose-dependent increase in weight loss observed in this study probably reflects the profound alteration in neuroendocrine functions associated with MW (Koob and Le Moal, 1997; Laorden et al., 1998).”
BackgroundNikolaou, K., Kapoukranidou, D., Ndungu, S., Floros, G., & Kovatsi, L. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1312644 · Cited by 18
Metadata
- Authors
- Laorden, M. L., Milanés, M. V., Chapleur-Château, M., & Burlet, A.
- Affiliations
- Universidad de Murcia (ES)
- Inserm (FR)
- Corresponding author
- Laorden, M.L
- ORCID
- Milanés, M.V
- Venue
- Neuropeptides
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 32
- Issue
- 1
- Pages
- 67-71
- ISSN
- 0143-4179 (ISSN-L)
- OpenAlex
- W1969388744
- Cited by
- 10
- References
- 33
- Citations by year
- 2023: 3 · 2020: 2 · 2019: 1 · 2017: 2
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuropeptides (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- oxytocin, morphine withdrawal, naloxone, opioid tolerance, opioid use disorder, hypothalamus, paraventricular nucleus, median eminence, arcuate nucleus, supraoptic nucleus, opioid withdrawal
- MeSH terms
- Animals, Drug Implants, Male, Median Eminence, Morphine, Morphine Dependence, Naloxone, Narcotic Antagonists, Oxytocin, Paraventricular Hypothalamic Nucleus, Substance Withdrawal Syndrome, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in oxytocin content in rat brain during morphine withdrawal. https://app.cochat.ai/papers/10.1016/s0143-4179(98)90019-1
- The paper
- Laorden, M. L., Milanés, M. V., Chapleur-Château, M., & Burlet, A. (1998). Changes in oxytocin content in rat brain during morphine withdrawal. Neuropeptides. https://doi.org/10.1016/s0143-4179(98)90019-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.